Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental …
Over the last 12 months, insiders at Envista Holdings Corp have bought $906,708 and sold $0 worth of Envista Holdings Corp stock.
On average, over the past 5 years, insiders at Envista Holdings Corp have bought $661,893 and sold $18.04M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Keel Paul A (Chief Executive Officer) — $1.01M. Hammes Eric D. (Chief Financial Officer) — $801,215.
The last purchase of 30,000 shares for transaction amount of $506,100 was made by Keel Paul A (Chief Executive Officer) on 2024‑08‑13.
2024-08-13 | Chief Executive Officer | 30,000 0.0181% | $16.87 | $506,100 | 0.00% | |||
2024-08-12 | Chief Financial Officer | 24,532 0.0144% | $16.33 | $400,608 | +17.63% | |||
2023-11-16 | SVP, Orthodontics | 2,185 0.0013% | $22.89 | $50,015 | -12.27% | |||
2023-11-08 | General Counsel | 5,000 0.0029% | $21.75 | $108,750 | -6.66% | |||
2023-11-06 | Chief Executive Officer | 10,000 0.0059% | $21.53 | $215,253 | -5.26% | |||
2023-11-06 | Principal Financial Officer | 2,000 0.0012% | $21.53 | $43,060 | -5.26% | |||
2023-02-28 | Sale | Chief Financial Officer | 10,016 0.006% | $37.90 | $379,606 | -17.47% | ||
2022-11-17 | Sale | Chief Financial Officer | 657 0.0004% | $36.55 | $24,013 | -6.69% | ||
2022-04-18 | Sale | Chief Financial Officer | 5,341 0.0033% | $45.73 | $244,244 | -16.99% | ||
2022-03-29 | Sale | Chief Executive Officer | 3,801 0.0025% | $51.50 | $195,752 | -22.61% | ||
2022-03-18 | Sale | Chief Executive Officer | 6,737 0.0041% | $49.75 | $335,166 | -23.85% | ||
2022-03-18 | Sale | Chief Financial Officer | 4,786 0.003% | $50.86 | $243,416 | -23.85% | ||
2022-03-18 | Sale | SVP, Strategy & Bus. Dev. | 10,092 0.0062% | $50.00 | $504,600 | -23.85% | ||
2022-03-16 | Sale | Chief Executive Officer | 8,982 0.0055% | $47.75 | $428,891 | -20.24% | ||
2022-03-01 | Sale | Chief Human Resources Officer | 4,181 0.0026% | $47.83 | $199,977 | -19.50% | ||
2022-03-01 | Sale | SVP, Strategy & Bus. Dev. | 2,958 0.0018% | $47.83 | $141,481 | -19.50% | ||
2022-02-25 | Sale | Chief Financial Officer | 7,196 0.0044% | $47.81 | $344,041 | -20.93% | ||
2022-02-25 | Sale | Chief Human Resources Officer | 16,892 0.0102% | $47.71 | $805,917 | -20.93% | ||
2022-02-25 | Sale | SVP, Strategy & Bus. Dev. | 18,574 0.0112% | $47.65 | $884,963 | -20.93% | ||
2022-02-11 | Sale | SVP, Strategy & Bus. Dev. | 12,112 0.0076% | $47.50 | $575,320 | -17.65% |
Keel Paul A | Chief Executive Officer | 402605 0.2339% | $18.95 | 1 | 0 | |
Hammes Eric D. | Chief Financial Officer | 24532 0.0143% | $18.95 | 1 | 0 | |
Aghdaei Amir | Chief Executive Officer | 295362 0.1716% | $18.95 | 2 | 12 | <0.0001% |
Conley Eric | SVP, Orthodontics | 47376 0.0275% | $18.95 | 1 | 0 | |
Bludworth Curt W | Chief Human Resources Officer | 46759 0.0272% | $18.95 | 1 | 6 | <0.0001% |
BlackRock | $442.78M | 12.05 | 20.71M | +13.3% | +$51.98M | 0.01 | |
The Vanguard Group | $366.44M | 9.97 | 17.14M | -0.17% | -$609,158.96 | 0.01 | |
Morgan Stanley | $361.43M | 9.84 | 16.91M | +3.81% | +$13.26M | 0.03 | |
Harris Associates | $208.66M | 5.68 | 9.76M | -10.07% | -$23.36M | 0.34 | |
Ariel Investments | $190.12M | 5.17 | 8.89M | +25.3% | +$38.38M | 1.87 |